No Renal Benefit for mTOR Inhibitors - MedPage Today PDF Print
MedPage TodayThe mTOR inhibitors everolimus (Zortress, Afinitor) and sirolimus (Rapamune) failed to halt the decline in renal function associated with autosomal dominant

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.

Notice: Undefined variable: query in /home/globaldi/public_html/components/com_joomlawatch/class.joomlawatch.db.php on line 129